Core Alternative Capital cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,651 shares of the healthcare conglomerate’s stock after selling 497 shares during the period. UnitedHealth Group accounts for about 2.0% of Core Alternative Capital’s portfolio, making the stock its 11th biggest position. Core Alternative Capital’s holdings in UnitedHealth Group were worth $10,171,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. Outfitter Financial LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Blue Bell Private Wealth Management LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $29,000. Tortoise Investment Management LLC grew its stake in UnitedHealth Group by 54.8% in the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares in the last quarter. Leverty Financial Group LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $34,000. Finally, Stuart Chaussee & Associates Inc. boosted its position in UnitedHealth Group by 55.6% during the 4th quarter. Stuart Chaussee & Associates Inc. now owns 70 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 25 shares in the last quarter. Institutional investors and hedge funds own 87.48% of the company’s stock.
NYSE UNH traded up $0.82 on Tuesday, reaching $490.04. The stock had a trading volume of 75,136 shares, compared to its average volume of 3,155,384. The firm has a market capitalization of $459.74 billion, a price-to-earnings ratio of 26.78, a P/E/G ratio of 1.51 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The stock has a fifty day moving average price of $511.42 and a two-hundred day moving average price of $485.09.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 22nd. Stockholders of record on Monday, March 14th were given a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s dividend payout ratio is currently 31.75%.
In related news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $476.72, for a total transaction of $2,383,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 6,000 shares of the business’s stock in a transaction on Friday, February 25th. The stock was sold at an average price of $470.38, for a total transaction of $2,822,280.00. The disclosure for this sale can be found here. Insiders have sold 18,000 shares of company stock worth $8,776,840 in the last ninety days. Corporate insiders own 0.55% of the company’s stock.
Several analysts have issued reports on UNH shares. Royal Bank of Canada set a $563.00 target price on UnitedHealth Group and gave the company an “outperform” rating in a research report on Monday, April 18th. Truist Financial raised their price objective on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Oppenheimer raised their target price on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. Raymond James raised their target price on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, April 19th. Finally, StockNews.com assumed coverage on UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. Two equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $550.17.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- The Institutions Are Capping Gains In Take-Two Interactive
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
- Beware The Rebound In Home Depot
- Time to Ride These 3 Mid Cap Momentum Plays
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.